Internal Medicine, Medical Oncology · North Venice, FL
NPI
1528269917
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5500 Pinebrook Rd Ste 202
North Venice, FL, 34275
Phone (941) 408-0500
Groups this clinician bills Medicare through
Medicare paid, 2024
$7.1M
471,720 services
Medicare patients, 2024
1,604
Average age 77
Drug cost, 2024
$6.5M
2,176 prescriptions
Company payments, 2025
$3,708
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andres O Soriano was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 109,140 times for 128 patients. In total Andres O Soriano billed 471,720 services in 192 codes, and Medicare paid $7.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 109,140 | 128 | $0.28 | $30K |
| J9025 Injection, azacitidine, 1 mg | Office | 35,100 | 17 | $0.30 | $10K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 27,200 | 27 | $44.51 | $1.2M |
| J9299 Injection, nivolumab, 1 mg | Office | 14,740 | 12 | $24.58 | $362K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 11,834 | 32 | $35.97 | $426K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 11,150 | 64 | $6.41 | $71K |
| J0185 Injection, aprepitant, 1 mg | Office | 10,920 | 32 | $1.34 | $15K |
| J9267 Injection, paclitaxel, 1 mg | Office | 10,807 | 19 | $0.08 | $886 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 10,440 | 13 | $39.61 | $414K |
| J0897 Injection, denosumab, 1 mg | Office | 10,260 | 90 | $20.51 | $210K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 8,900 | 81 | $15.82 | $141K |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 8,880 | 15 | $0.22 | $1,943 |
| J1434 Injection, fosaprepitant (focinvez), 1 mg | Office | 6,150 | 16 | $2.31 | $14K |
| 85025 Blood Count | Office | 3,885 | 1,151 | $7.60 | $30K |
| 36415 Venipuncture Blood Collection | Office | 3,793 | 1,197 | $8.65 | $33K |
By year: 2022 $6.3M for 434,787 services; 2023 $6.2M for 443,427 services; 2024 $7.1M for 471,720 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 3,885 | 1,151 | $7.60 | $30K |
| 36415 Venipuncture Blood Collection | 3,793 | 1,197 | $8.65 | $33K |
| 85610 Clinical Chemistry | 164 | 20 | $4.20 | $689 |
| 85046 Blood Count | 111 | 108 | $5.46 | $606 |
| 81003 Clinical Chemistry | 65 | 40 | $2.20 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Andres O Soriano prescribed most often to Medicare patients was Prednisone, with 148 prescriptions and refills. In total Andres O Soriano wrote 2,176 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 148 | 217 | 52 | $1,099 |
| Anastrozole Generic | 146 | 404 | 41 | $3,170 |
| Acyclovir Generic | 110 | 232 | 31 | $2,266 |
| Ondansetron Odt Ondansetron | 106 | 106 | 73 | $1,870 |
| Gabapentin Generic | 90 | 127 | 33 | $869 |
| Hydroxyurea Generic | 86 | 213 | 22 | $2,222 |
| Eliquis Apixaban | 79 | 107 | 20 | $61K |
| Revlimid Lenalidomide | 76 | 76 | Under 11 | $1.3M |
| Brukinsa Zanubrutinib | 74 | 74 | Under 11 | $979K |
| Abiraterone Acetate Generic | 54 | 58 | Under 11 | $134K |
| Dexamethasone Generic | 49 | 81 | 20 | $1,394 |
| Allopurinol Generic | 46 | 78 | 17 | $451 |
| Tamoxifen Citrate Generic | 43 | 121 | 14 | $1,348 |
| Tramadol Hcl Generic | 41 | 41 | 31 | $319 |
| Sprycel Dasatinib | 41 | 41 | Under 11 | $112K |
Brand drugs: 571 claims; generic drugs: 1,605 claims; opioid claims: 111.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andres O Soriano $3,708 ($3,708 in general payments such as food, travel and fees) from 38 companies. The largest payer was Merck Sharp & Dohme LLC with $291.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 12 | $291 |
| Pfizer Inc. PFE | 14 | $266 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $222 |
| GlaxoSmithKline, LLC. GSK | 5 | $217 |
| Incyte Corporation INCY | 8 | $198 |
| Daiichi Sankyo Inc. 4568.T | 7 | $182 |
| Array Biopharma Inc PFE | 6 | $182 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $169 |
| Intuitive Surgical, Inc. ISRG | 1 | $135 |
| Gilead Sciences, Inc. GILD | 7 | $135 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.